HER2-positive (HER2+) metastatic breast cancer (MBC) presentation and patterns of progression.
Serena Di Cosimo
No relevant relationships to disclose
Danila Serpico
No relevant relationships to disclose
Luca Porcu
No relevant relationships to disclose
Anna Tessari
No relevant relationships to disclose
Leonardo Molino
No relevant relationships to disclose
Valter Torri
No relevant relationships to disclose
Filippo de Braud
Consultant or Advisory Role - Novartis; SERVIER
Research Funding - GlaxoSmithKline; Novartis; Pierre Fabre Medicament; Roche